44325
21273
HDFC Pharma and Healthcare Fund - Direct (G)
21.15
2.82
9.10
12.09
12.10
30.31
7
1.21
21.15
HDFC Pharma and Healthcare Fund - Direct (G)
1.2
19.74
1.04
3.5
1 Year

SIP TrendupInvest in Mutual Funds at 0 Transaction cost

Start Investing
  • NAV

    20.03

    19 May 2026

  • 0.72%

     1 Day

Note: Data shown is for Direct Plan. Our Platform offers Regular Plans only. Returns may differ due to expense ratio differences.
One click to compare funds with our smart tool—analyze returns & more! Compare
  • ₹ 100

    Min SIP
  • ₹ 100

    Min Lumpsum
  • 1.22%

    Expense Ratio
  • NA

    Rating
  • 2,159 Cr

    Fund Size
  • 2 Years

    Fund Age

SIP Calculator

Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00
Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00

Returns and Ranks ( as on 19 May 2026 )

  • 1Y Returns
  • 3Y Returns
  • 5Y Returns
  • MAX Returns
  • Trailing Returns
  • 21.15%
  • 30.31
  • 19.09Alpha
  • 4.89SD
  • 0.69Beta
  • 1.08Sharpe
  • Exit Load
  • In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment.
  • Tax implication
  • Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
To provide long-term capital appreciation by investing predominantly in equity and equity related s securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
Low Low to
moderate
Moderate Moderately
High
High Very
High
  • Address :
  • HDFC House, 2nd Flr, H.T.Parekh Marg, 165-166, Backbay Reclamation, Churchgate, Mumbai - 400 020.
    • Contact :
    • +91022 - 6631 6333
    • Email ID :
    • hello@hdfcfund.com

FAQs

HDFC Pharma and Healthcare Fund - Direct (G) has delivered 39.17% since inception

The NAV of HDFC Pharma and Healthcare Fund - Direct (G) is ₹13.917 as of 19 May 2026

The expense ratio of HDFC Pharma and Healthcare Fund - Direct (G) is 1.22 % as of 19 May 2026

The AUM of HDFC Pharma and Healthcare Fund - Direct (G) 828.19 CR as of 19 May 2026

The minimum SIP amount of HDFC Pharma and Healthcare Fund - Direct (G) is 100

The top stock holdings of HDFC Pharma and Healthcare Fund - Direct (G) are

  1. Divi's Lab. - 8.56%
  2. Sun Pharma.Inds. - 8.05%
  3. Lupin - 6.07%
  4. Glenmark Pharma. - 6.06%
  5. Max Healthcare - 5.93%

The top sectors HDFC Pharma and Healthcare Fund - Direct (G) has invested in are

  1. Pharmaceuticals & Biotech - 74.04%
  2. Healthcare Services - 23.7%
  3. Retailing - 1.21%
  4. Debt - 0.91%
  5. Insurance - 0.44%

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form